Jump Financial, LLC Eye Point Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.58 - $10.54 $776,358 - $1.08 Million	-102,422 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$8.16 - $22.89 $835,763 - $2.34 Million	102,422 New	102,422 $891,000
Q4 2023 Oct 21, 2024	SELL	$5.71 - $24.13 $143,743 - $607,448	-25,174 Reduced 51.41%	23,794 $549,000
Q4 2023 Feb 07, 2024	SELL	$5.71 - $24.13 $143,743 - $607,448	-25,174 Reduced 51.41%	23,794 $549,000
Q3 2023 Oct 21, 2024	BUY	$7.99 - $15.36 $297,771 - $572,436	37,268 Added 318.53%	48,968 $391,000
Q3 2023 Nov 07, 2023	BUY	$7.99 - $15.36 $297,771 - $572,436	37,268 Added 318.53%	48,968 $391,000
Q2 2023 Oct 21, 2024	SELL	$3.03 - $9.0 $274,887 - $816,498	-90,722 Reduced 88.58%	11,700 $101,000
Q2 2023 Aug 07, 2023	BUY	$3.03 - $9.0 $35,451 - $105,300	11,700 New	11,700 $101,000
Q3 2022 Nov 07, 2022	BUY	$6.96 - $11.12 $4,176 - $6,671	600 Added 3.64%	17,100 $135,000
Q2 2022 Aug 09, 2022	BUY	$7.25 - $12.71 $2,900 - $5,084	400 Added 2.48%	16,500 $130,000
Q1 2022 May 12, 2022	BUY	$8.67 - $14.11 $139,587 - $227,171	16,100 New	16,100 $196,000

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $357M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.